Press-release for stocks for NVSEF

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : NVSEF

save search

Europe Frontotemporal Dementia Market Research Report 2023: Growing Prevalence of Dementia & Increasing Number of Clinical Trials - Competition, Forecasts & Opportunities to 2028
Published: 2023-04-26 (Crawled : 15:20) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40

|

Health Technology

| 6.15% | O: -4.57% H: 0.22% C: -1.98%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -17.96% | O: -1.46% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 7.63% | O: 0.0% H: 0.0% C: 0.0%
VTRS | $11.12 0.18% 0.09% 2.3M

|

Health Technology

| 21.13% | O: 0.22% H: 0.65% C: -1.09%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -10.53% | O: 0.62% H: 0.0% C: -2.04%
JNJ | News | $145.74 0.67% -0.18% 7M

|

Health Technology

| -12.25% | O: -0.66% H: 0.18% C: -0.9%
GSK | $39.27 -0.83% 0.26% 1.9M

|

Health Technology

| 7.29% | O: -0.03% H: 0.3% C: -2.63%
SNY | News | $45.39 -1.56% -1.58% 4.3M

|

Health Technology

| -20.82% | O: 0.53% H: 0.0% C: 0.0%
CNTG | $0.461 -3.96% -4.12% 23K

|

Commercial Services

| -70.55% | O: 1.23% H: 27.27% C: -15.76%
europe report dementia trials research growing market

Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
Published: 2022-03-08 (Crawled : 17:00) - voyagertherapeutics.com
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 11.07% | O: -4.98% H: 0.0% C: 0.0%
VYGR | $7.55 -2.46% -2.52% 880K

|

Health Technology

| 106.28% | O: 31.15% H: 19.58% C: 9.17%
therapeutics report results

2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Published: 2024-01-17 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -12.65% | O: 0.0% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -14.02% | O: -0.78% H: 0.59% C: 0.57%
VRNA | $16.1 -1.83% -1.86% 490K

|

Health Technology

| -6.61% | O: 0.52% H: 2.31% C: -0.87%
NKTR | $1.32 -2.22% -3.85% 2.4M

|

Health Technology

| 173.5% | O: -0.73% H: 12.24% C: 12.24%
companies report pipeline research key

Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $25.39 -0.12% 0.24% 31M

|

Health Technology

| -10.59% | O: 0.39% H: 0.82% C: -0.74%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -13.6% | O: 0.22% H: 0.43% C: -0.39%
SRNE | $0.024 -14.29% -8.85% 57K

|

Health Technology

| -33.33% | O: -63.33% H: 263.64% C: 127.27%
GILD | News | $66.16 -1.15% -1.16% 4.9M

|

Health Technology

| -15.83% | O: 0.1% H: 0.43% C: -0.04%
AUTL | $4.8 -0.83% -0.83% 1.2M

|

Health Technology

| -11.96% | O: -0.91% H: 11.52% C: 4.94%
drug report t-cell global therapy market

RNAi Drug Delivery Market worth $109.73 billion between 2022-2027- Exclusive report by Technavio
Published: 2023-07-27 (Crawled : 08:00) - prnewswire.com
RNAZ | $0.502 0.1% 3.46% 270K

|

Professional, Scientific, and T...

| -78.26% | O: 2.57% H: 3.43% C: 0.47%
TMO | News | $541.52 -1.05% -0.1% 1.8M

|

Health Technology

| -7.21% | O: 0.17% H: 0.35% C: -2.67%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -10.41% | O: 0.7% H: 0.12% C: -0.76%
SLN | $22.02 2.13% 1.91% 120K

|

Health Technology

| 302.24% | O: 2.61% H: 0.27% C: -2.18%
SNY | News | $45.39 -1.56% -1.58% 4.3M

|

Health Technology

| -14.23% | O: 0.92% H: 0.0% C: 0.0%
BNTX | $86.17 -0.27% -0.24% 520K

|

Health Technology

| -19.47% | O: -0.64% H: 0.0% C: 0.0%
BNTC | News | $6.82 42.08% 30.64% 3.5M

|

Health Technology

| 84.32% | O: -8.92% H: 9.49% C: 0.59%
drug report market

REGENXBIO Reports Third Quarter 2021 Financial Results and Operational Highlights
Published: 2021-11-02 (Crawled : 20:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 11.94% | O: -0.7% H: 0.82% C: 0.82%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 11.14% | O: -0.59% H: 0.67% C: 0.4%
SLDB | $9.26 -7.31% -8.12% 140K

|

Health Technology

| 371.23% | O: 1.89% H: 9.26% C: 8.8%
RGNX | $16.11 -5.4% -5.91% 560K

|

Health Technology

| -53.46% | O: 4.62% H: 1.4% C: -1.41%
financial results results

Soft Contact Lens Market: 40% of Growth to Originate from APAC, Evolving Opportunities with BenQ Corp. & Cantor and Nissel Ltd. - Technavio
Published: 2022-09-07 (Crawled : 08:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 47.07% | O: 4.71% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 16.69% | O: 0.66% H: 0.88% C: 0.8%
BHC | $8.6 -0.69% 0.0% 2.2M

|

Health Technology

| 34.67% | O: -0.15% H: 9.26% C: 7.25%
growth

Insights on the Non-Melanoma Skin Cancer Treatment Global Market to 2026 - by Treatment Type, Indication, End-use and Region
Published: 2021-11-01 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 11.47% | O: -0.42% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 12.47% | O: 1.3% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M

|

Health Technology

| 194.7% | O: 0.18% H: 0.0% C: 0.0%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -17.29% | O: -0.17% H: 1.58% C: 0.65%
ICAD | $1.59 1.92% 0.64% 140K

|

Technology Services

| -85.21% | O: 0.0% H: 0.85% C: -0.57%
ARAY | $2.21 0.91% 0.9% 690K

|

Health Technology

| -55.71% | O: 0.0% H: 8.82% C: 7.01%
treatment skin cancer cancer skin

BeiGene Reports First Quarter 2022 Financial Results
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 6.4% | O: -0.39% H: 0.15% C: -1.07%
BGNE | $131.96 0.08% 0.06% 110K

|

Health Technology

| -16.9% | O: 0.98% H: 7.7% C: -2.09%
results

Uveitis Drugs Market, High Prevalence Of Eye Disorders And Associated Risk Factors Of Uveitis to Boost Market Growth - Technavio
Published: 2022-08-08 (Crawled : 22:00) - prnewswire.com
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 8.31% | O: 1.28% H: 0.8% C: 0.13%
BHC | $8.6 -0.69% 0.0% 2.2M

|

Health Technology

| 49.66% | O: -7.02% H: 7.55% C: -4.6%
ABBV | News | $164.66 0.25% -0.14% 3.6M

|

Health Technology

| 17.69% | O: 0.24% H: 1.11% C: -0.31%
BIIB | $190.52 -0.85% -0.84% 1.3M

|

Health Technology

| -10.3% | O: -0.56% H: 1.04% C: 0.58%
AMGN | $262.75 -0.5% -0.49% 1.4M

|

Health Technology

| 7.14% | O: -0.03% H: 1.02% C: 0.47%
risk eye growth market

Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 43.49% | O: 1.13% H: 0.0% C: 0.0%
TAK | News | $13.16 0.08% 0.53% 1.2M

|

Health Technology

| -0.53% | O: 0.68% H: 1.05% C: -0.23%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 14.73% | O: 0.47% H: 0.09% C: -0.55%
XNCR | $18.95 -0.63% -0.47% 470K

|

Health Technology

| -31.89% | O: 1.07% H: 2.51% C: -0.11%
MOR | $18.05 0.06% -0.11% 590K

|

Health Technology

| 272.93% | O: 3.1% H: 1.8% C: -0.6%
INCY | $52.82 0.19% 0.19% 1.5M

|

Health Technology

| -28.95% | O: 1.59% H: 7.26% C: 1.89%
financial results

Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40

|

Health Technology

| 29.9% | O: -0.06% H: 0.0% C: 0.0%
AZNCF | $138.24 -1.36% -4.19% 800

|

Health Technology

| 12.29% | O: 6.22% H: 3.13% C: -0.56%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 12.19% | O: 2.81% H: 0.43% C: -0.2%
JNJ | News | $145.74 0.67% -0.18% 7M

|

Health Technology

| -16.77% | O: 0.18% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M

|

Health Technology

| 22.15% | O: 2.59% H: 0.72% C: 0.63%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -39.46% | O: 1.22% H: 0.01% C: -1.7%
IOVA M | $11.72 -0.68% -0.68% 3.7M

|

Health Technology

| 50.51% | O: 6.12% H: 4.99% C: 4.21%
INO | $10.2 -7.86% -8.32% 400K

|

Health Technology

| 367.89% | O: 5.5% H: 4.35% C: 3.48%
GILD | News | $66.16 -1.15% -1.16% 4.9M

|

Health Technology

| -18.73% | O: 1.43% H: 0.36% C: -1.08%
ATRA | $0.6917 -3.25% -3.35% 770K

|

Health Technology

| -82.43% | O: 2.58% H: 23.12% C: 20.85%
AZN | $68.36 -0.25% -0.25% 3.6M

|

Health Technology

| 11.82% | O: 7.08% H: 0.84% C: -0.43%
ADAP | $0.8984 -8.98% -9.86% 3.3M

|

Health Technology

| -50.95% | O: 0.0% H: 7.14% C: 5.71%
covid-19 research global immunotherapy report impact technology market

USD 8 Bn growth opportunity in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market | North America to emerge as key market | Technavio
Published: 2022-05-25 (Crawled : 04:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800

|

Health Technology

| 2.15% | O: -1.42% H: 2.73% C: 2.73%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 24.44% | O: 0.89% H: 0.0% C: 0.0%
VTRS | $11.12 0.18% 0.09% 2.3M

|

Health Technology

| -3.56% | O: -0.26% H: 3.13% C: 2.96%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 2.15% | O: 0.29% H: 0.0% C: 0.0%
PBYI | $4.99 -3.48% -3.82% 290K

|

Health Technology

| 176.47% | O: -1.6% H: 6.52% C: 3.8%
AZN | $68.36 -0.25% -0.25% 3.6M

|

Health Technology

| 2.27% | O: -0.45% H: 0.89% C: 0.54%
AMGN | $262.75 -0.5% -0.49% 1.4M

|

Health Technology

| 6.21% | O: 1.42% H: 0.72% C: 0.0%
america growth market her2- her2

Global Lupus Therapeutic Market to Surpass US$ 5,408.1 Million by 2030, Says Coherent Market Insights
Published: 2022-03-16 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40

|

Health Technology

| -3.16% | O: -0.46% H: 3.49% C: 3.49%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 15.32% | O: 2.25% H: 0.0% C: 0.0%
UCBJY | $63.676 -0.62% -4.38% 7.2K

|

| 16.13% | O: 1.41% H: 2.33% C: 0.04%
TAK | News | $13.16 0.08% 0.53% 1.2M

|

Health Technology

| -9.25% | O: 2.07% H: 1.62% C: 1.56%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 10.49% | O: 0.74% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M

|

Health Technology

| -5.04% | O: 0.41% H: 0.0% C: 0.0%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -30.75% | O: 0.26% H: 0.31% C: -0.39%
SNY | News | $45.39 -1.56% -1.58% 4.3M

|

Health Technology

| -11.53% | O: 0.82% H: 0.0% C: 0.0%
AUPH | $4.81 -2.04% -2.08% 2.1M

|

Health Technology

| -54.15% | O: 0.95% H: 6.23% C: 5.19%
AMGN | $262.75 -0.5% -0.49% 1.4M

|

Health Technology

| 14.41% | O: 0.41% H: 0.0% C: -0.37%
lupus market

Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026 | Market is driven by the increasing prevalence of chronic disease - Technavio
Published: 2023-10-24 (Crawled : 02:00) - prnewswire.com
ALPMY | $9.47 0.11% -1.11% 520K

|

| -28.04% | O: -0.4% H: 1.18% C: 0.17%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -1.7% | O: -0.17% H: 1.02% C: 0.4%
BCLI | $0.5143 -4.9% -7.51% 1.1M

|

Health Technology

| 203.75% | O: -0.3% H: 6.21% C: -8.0%
disease cell therapy market

Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer
Published: 2023-09-27 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 11.81% | O: 1.99% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -8.22% | O: -0.13% H: 0.06% C: -1.02%
CERS | News | $1.64 0.3% 610K

|

Health Technology

| 6.49% | O: -1.3% H: 5.92% C: 0.66%
corporation

REGENXBIO Reports First Quarter 2023 Financial Results and Recent Operational Highlights
Published: 2023-05-03 (Crawled : 00:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 10.16% | O: -1.96% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -10.1% | O: 0.55% H: 0.68% C: 0.33%
QURE | $4.71 0.86% 0.85% 440K

|

Health Technology

| -76.65% | O: 0.4% H: 3.8% C: 2.37%
RARE F | $43.38 -1.65% -1.68% 770K

|

Health Technology

| 3.76% | O: 0.92% H: 3.17% C: 1.0%
RGNX | $16.11 -5.4% -5.91% 560K

|

Health Technology

| -12.62% | O: 0.05% H: 5.85% C: 3.74%
financial results

Dennis Huang of Ultragenyx Named to MassBio’s Board of Directors
Published: 2023-04-28 (Crawled : 17:00) - globenewswire.com
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -9.32% | O: -0.79% H: 0.89% C: 0.72%
RARE F | $43.38 -1.65% -1.68% 770K

|

Health Technology

| 3.89% | O: -0.52% H: 5.85% C: 3.39%

Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets
Published: 2023-03-06 (Crawled : 12:00) - ir.voyagertherapeutics.com
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 34.89% | O: 2.04% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| 9.92% | O: 0.34% H: 0.76% C: -0.06%
VYGR | $7.55 -2.46% -2.52% 880K

|

Health Technology

| 3.28% | O: 5.47% H: 5.45% C: 3.24%
disease license therapeutics payment

Global $500+ Mn Neurotrophic Keratitis Markets, 2023-2028: Empowering Vision Health - Neurotrophic Keratitis Market on the Rise
Published: 2023-08-25 (Crawled : 17:00) - prnewswire.com
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -7.7% | O: 0.67% H: 0.37% C: 0.26%
JNJ | News | $145.74 0.67% -0.18% 7M

|

Health Technology

| -11.62% | O: 0.51% H: 0.0% C: 0.0%
ABBV | News | $164.66 0.25% -0.14% 3.6M

|

Health Technology

| 12.22% | O: -0.11% H: 0.44% C: -0.22%
KALA | $6.81 -0.41% -0.12% 9.3K

|

Health Technology

| -50.04% | O: -1.31% H: 0.85% C: 0.67%
BBIO | $24.95 -0.12% 0.0% 2.2M

|

Health Technology

| -11.15% | O: 0.71% H: 5.34% C: 4.95%
health global market

← Previous
1
2
3
4
5
6
7
8
9
…
51
52
Next →

Gainers vs Losers

60%

40%

Top 10 Gainers

AGBA | News | $1.03 157.5% 57.94% 120M

|

ZCMD | $1.45 5.84% 52.1% 2.3M

|

Commercial Services

INVO | $1.52 100.0% 51.13% 5M

|

Health Technology

ISPC | $0.421 97.65% 49.53% 37M

|

Professional, Scientific, and T...

WLGS | News | $0.5 45.65% 470K

|

OST | $0.509 23.81% 45.26% 90K

|

GDHG | $0.263 21.76% 40.66% 3.1M

|

XPON | News | $3.15 63.21% 37.74% 16M

|

TIRX | $0.8 65.02% 30.74% 58M

|

BNTC | News | $6.82 42.08% 30.64% 3.5M

|

Health Technology

Your saved searches

Save your searches and get alerts when important news are released.